IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 394 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,090,241 | +9.1% | 68,127 | -1.4% | 0.01% | 0.0% |
| Q2 2023 | $2,833,655 | -59.8% | 69,063 | -60.9% | 0.01% | -81.2% |
| Q2 2021 | $7,054,000 | +12.1% | 176,820 | +58.9% | 0.03% | -5.9% |
| Q4 2020 | $6,291,000 | +133.2% | 111,269 | +95.7% | 0.03% | +100.0% |
| Q3 2020 | $2,698,000 | +4323.0% | 56,862 | +5496.7% | 0.02% | – |
| Q4 2019 | $61,000 | +79.4% | 1,016 | +81.1% | 0.00% | – |
| Q3 2019 | $34,000 | +325.0% | 561 | +523.3% | 0.00% | – |
| Q1 2019 | $8,000 | -99.1% | 90 | -99.5% | 0.00% | -100.0% |
| Q3 2018 | $922,000 | -88.4% | 17,878 | -86.1% | 0.00% | -94.7% |
| Q4 2015 | $7,947,000 | – | 128,328 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |